Brussels, 07/03/2016 (Agence Europe) - The European Union has a new system for optimising the development of priority medicines and facilitating patients' access. On Monday 7 March, the European Medicines Agency (EMA) launched its PRIME programme to provide scientific and regulatory support in the development of medicines where it is needed.
Vytenis Andriukaitis, EU commissioner for health and food safety, said “The launch of PRIME is a major step forward for patients and their families...